Veracyte, Inc. (NASDAQ:VCYT) reported strong quarterly results, beating revenue and earnings estimates. Analysts raised revenue and earnings forecasts, showing optimism in the company's prospects. The consensus price target also increased, indicating positive sentiment and potential growth.